Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986 Jun;79(6):347–352. doi: 10.1177/014107688607900612

Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper.

P J Harrison
PMCID: PMC1290346  PMID: 2873250

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amaral D. G., Price J. L. Amygdalo-cortical projections in the monkey (Macaca fascicularis). J Comp Neurol. 1984 Dec 20;230(4):465–496. doi: 10.1002/cne.902300402. [DOI] [PubMed] [Google Scholar]
  2. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol. 1983;61(2):101–108. doi: 10.1007/BF00697388. [DOI] [PubMed] [Google Scholar]
  3. Averback P. Lesions of the nucleus ansae peduncularis in neuropsychiatric disease. Arch Neurol. 1981 Apr;38(4):230–235. doi: 10.1001/archneur.1981.00510040056009. [DOI] [PubMed] [Google Scholar]
  4. Ball M. J., Fisman M., Hachinski V., Blume W., Fox A., Kral V. A., Kirshen A. J., Fox H., Merskey H. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet. 1985 Jan 5;1(8419):14–16. doi: 10.1016/s0140-6736(85)90965-1. [DOI] [PubMed] [Google Scholar]
  5. Bartus R. T., Dean R. L., 3rd, Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982 Jul 30;217(4558):408–414. doi: 10.1126/science.7046051. [DOI] [PubMed] [Google Scholar]
  6. Bondareff W. Age and Alzheimer disease. Lancet. 1983 Jun 25;1(8339):1447–1447. doi: 10.1016/s0140-6736(83)92396-6. [DOI] [PubMed] [Google Scholar]
  7. Bondareff W., Mountjoy C. Q., Roth M. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet. 1981 Apr 4;1(8223):783–784. doi: 10.1016/s0140-6736(81)92657-x. [DOI] [PubMed] [Google Scholar]
  8. Bowen D. M., Smith C. B., White P., Davison A. N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 1976 Sep;99(3):459–496. doi: 10.1093/brain/99.3.459. [DOI] [PubMed] [Google Scholar]
  9. Brown R. G., Marsden C. D. How common is dementia in Parkinson's disease? Lancet. 1984 Dec 1;2(8414):1262–1265. doi: 10.1016/s0140-6736(84)92807-1. [DOI] [PubMed] [Google Scholar]
  10. Brun A., Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology. 1981 Sep;5(5):549–564. doi: 10.1111/j.1365-2559.1981.tb01818.x. [DOI] [PubMed] [Google Scholar]
  11. Candy J. M., Perry R. H., Perry E. K., Irving D., Blessed G., Fairbairn A. F., Tomlinson B. E. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci. 1983 May;59(2):277–289. doi: 10.1016/0022-510x(83)90045-x. [DOI] [PubMed] [Google Scholar]
  12. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983 Mar 11;219(4589):1184–1190. doi: 10.1126/science.6338589. [DOI] [PubMed] [Google Scholar]
  13. Crapper D. R., Krishnan S. S., Dalton A. J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science. 1973 May 4;180(4085):511–513. doi: 10.1126/science.180.4085.511. [DOI] [PubMed] [Google Scholar]
  14. Cross A. J., Crow T. J., Johnson J. A., Joseph M. H., Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci. 1983 Aug-Sep;60(3):383–392. doi: 10.1016/0022-510x(83)90149-1. [DOI] [PubMed] [Google Scholar]
  15. Davies P., Katzman R., Terry R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980 Nov 20;288(5788):279–280. doi: 10.1038/288279a0. [DOI] [PubMed] [Google Scholar]
  16. Davies P., Maloney A. J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976 Dec 25;2(8000):1403–1403. doi: 10.1016/s0140-6736(76)91936-x. [DOI] [PubMed] [Google Scholar]
  17. Deakin J. F. Alzheimer's disease: recent advances and future prospects. Br Med J (Clin Res Ed) 1983 Nov 5;287(6402):1323–1324. doi: 10.1136/bmj.287.6402.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Esiri M. M. Viruses and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1982 Aug;45(8):759–760. doi: 10.1136/jnnp.45.8.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fudenberg H. H., Whitten H. D., Arnaud P., Khansari N. Is Alzheimer's disease an immunological disorder? Observations and speculations. Clin Immunol Immunopathol. 1984 Aug;32(2):127–131. doi: 10.1016/0090-1229(84)90114-4. [DOI] [PubMed] [Google Scholar]
  20. Herzog A. G., Kemper T. L. Amygdaloid changes in aging and dementia. Arch Neurol. 1980 Oct;37(10):625–629. doi: 10.1001/archneur.1980.00500590049006. [DOI] [PubMed] [Google Scholar]
  21. Hyman B. T., Van Hoesen G. W., Damasio A. R., Barnes C. L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 1984 Sep 14;225(4667):1168–1170. doi: 10.1126/science.6474172. [DOI] [PubMed] [Google Scholar]
  22. Johnston M. V., McKinney M., Coyle J. T. Neocortical cholinergic innervation: a description of extrinsic and intrinsic components in the rat. Exp Brain Res. 1981;43(2):159–172. doi: 10.1007/BF00237760. [DOI] [PubMed] [Google Scholar]
  23. Jones E. G., Burton H., Saper C. B., Swanson L. W. Midbrain, diencephalic and cortical relationships of the basal nucleus of Meynert and associated structures in primates. J Comp Neurol. 1976 Jun 15;167(4):385–419. doi: 10.1002/cne.901670402. [DOI] [PubMed] [Google Scholar]
  24. Jones E. G., Powell T. P. An anatomical study of converging sensory pathways within the cerebral cortex of the monkey. Brain. 1970;93(4):793–820. doi: 10.1093/brain/93.4.793. [DOI] [PubMed] [Google Scholar]
  25. Kemp J. M., Powell T. P. The cortico-striate projection in the monkey. Brain. 1970;93(3):525–546. doi: 10.1093/brain/93.3.525. [DOI] [PubMed] [Google Scholar]
  26. Kievit J., Kuypers H. G. Basal forebrain and hypothalamic connection to frontal and parietal cortex in the Rhesus monkey. Science. 1975 Feb 21;187(4177):660–662. doi: 10.1126/science.1114317. [DOI] [PubMed] [Google Scholar]
  27. Marchbanks R. M. Biochemistry of Alzheimer's dementia. J Neurochem. 1982 Jul;39(1):9–15. doi: 10.1111/j.1471-4159.1982.tb04695.x. [DOI] [PubMed] [Google Scholar]
  28. McKinney M., Davies P., Coyle J. T. Somatostatin is not co-localized in cholinergic neurons innervating the rat cerebral cortex-hippocampal formation. Brain Res. 1982 Jul 8;243(1):169–172. doi: 10.1016/0006-8993(82)91133-7. [DOI] [PubMed] [Google Scholar]
  29. Mesulam M. M., Mufson E. J. Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain. 1984 Mar;107(Pt 1):253–274. doi: 10.1093/brain/107.1.253. [DOI] [PubMed] [Google Scholar]
  30. Morrison J. H., Rogers J., Scherr S., Benoit R., Bloom F. E. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature. 1985 Mar 7;314(6006):90–92. doi: 10.1038/314090a0. [DOI] [PubMed] [Google Scholar]
  31. Nakano I., Hirano A. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol. 1984 May;15(5):415–418. doi: 10.1002/ana.410150503. [DOI] [PubMed] [Google Scholar]
  32. Pearce B. R., Palmer A. M., Bowen D. M., Wilcock G. K., Esiri M. M., Davison A. N. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. Neurochem Pathol. 1984;2(4):221–232. [PubMed] [Google Scholar]
  33. Pearson R. C., Esiri M. M., Hiorns R. W., Wilcock G. K., Powell T. P. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4531–4534. doi: 10.1073/pnas.82.13.4531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pearson R. C., Sofroniew M. V., Cuello A. C., Powell T. P., Eckenstein F., Esiri M. M., Wilcock G. K. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res. 1983 Dec 19;289(1-2):375–379. doi: 10.1016/0006-8993(83)90046-x. [DOI] [PubMed] [Google Scholar]
  35. Perry E. K., Gibson P. H., Blessed G., Perry R. H., Tomlinson B. E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci. 1977 Nov;34(2):247–265. doi: 10.1016/0022-510x(77)90073-9. [DOI] [PubMed] [Google Scholar]
  36. Plum F. Dementia: an approaching epidemic. Nature. 1979 May 31;279(5712):372–373. doi: 10.1038/279372a0. [DOI] [PubMed] [Google Scholar]
  37. Richter J. A., Perry E. K., Tomlinson B. E. Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci. 1980 May 19;26(20):1683–1689. doi: 10.1016/0024-3205(80)90176-9. [DOI] [PubMed] [Google Scholar]
  38. Roberts G. W., Crow T. J., Polak J. M. Location of neuronal tangles in somatostatin neurones in Alzheimer's disease. Nature. 1985 Mar 7;314(6006):92–94. doi: 10.1038/314092a0. [DOI] [PubMed] [Google Scholar]
  39. Roberts P. J., McBean G. J., Sharif N. A., Thomas E. M. Striatal glutamatergic function: modifications following specific lesions. Brain Res. 1982 Mar 4;235(1):83–91. doi: 10.1016/0006-8993(82)90197-4. [DOI] [PubMed] [Google Scholar]
  40. Rossor M. N., Iversen L. L., Reynolds G. P., Mountjoy C. Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984 Mar 31;288(6422):961–964. doi: 10.1136/bmj.288.6422.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rossor M. N. Neurotransmitters and CNS disease. Dementia. Lancet. 1982 Nov 27;2(8309):1200–1204. doi: 10.1016/s0140-6736(82)91212-0. [DOI] [PubMed] [Google Scholar]
  42. Rossor M. N. Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. Br Med J (Clin Res Ed) 1981 Dec 12;283(6306):1588–1590. doi: 10.1136/bmj.283.6306.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rylett R. J., Ball M. J., Colhoun E. H. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res. 1983 Dec 19;289(1-2):169–175. doi: 10.1016/0006-8993(83)90017-3. [DOI] [PubMed] [Google Scholar]
  44. Shute C. C., Lewis P. R. The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain. 1967 Sep;90(3):497–520. doi: 10.1093/brain/90.3.497. [DOI] [PubMed] [Google Scholar]
  45. Simpson J., Yates C. M., Gordon A., St Clair D. M. Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea. J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1138–1139. doi: 10.1136/jnnp.47.10.1138-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sims N. R., Bowen D. M., Smith C. C., Flack R. H., Davison A. N., Snowden J. S., Neary D. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet. 1980 Feb 16;1(8164):333–336. doi: 10.1016/s0140-6736(80)90884-3. [DOI] [PubMed] [Google Scholar]
  47. Sitaram N., Weingartner H., Gillin J. C. Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Science. 1978 Jul 21;201(4352):274–276. doi: 10.1126/science.351808. [DOI] [PubMed] [Google Scholar]
  48. Sofroniew M. V., Pearson R. C., Eckenstein F., Cuello A. C., Powell T. P. Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage. Brain Res. 1983 Dec 19;289(1-2):370–374. doi: 10.1016/0006-8993(83)90045-8. [DOI] [PubMed] [Google Scholar]
  49. Struble R. G., Cork L. C., Whitehouse P. J., Price D. L. Cholinergic innervation in neuritic plaques. Science. 1982 Apr 23;216(4544):413–415. doi: 10.1126/science.6803359. [DOI] [PubMed] [Google Scholar]
  50. Taylor G. R., Crow T. J., Markakis D. A., Lofthouse R., Neeley S., Carter G. I. Herpes simplex virus and Alzheimer's disease: a search for virus DNA by spot hybridisation. J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1061–1065. doi: 10.1136/jnnp.47.10.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Terry R. D., Katzman R. Senile dementia of the Alzheimer type. Ann Neurol. 1983 Nov;14(5):497–506. doi: 10.1002/ana.410140502. [DOI] [PubMed] [Google Scholar]
  52. Tucek S. Regulation of acetylcholine synthesis in the brain. J Neurochem. 1985 Jan;44(1):11–24. doi: 10.1111/j.1471-4159.1985.tb07106.x. [DOI] [PubMed] [Google Scholar]
  53. Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand. 1974;50(5):539–547. doi: 10.1111/j.1600-0447.1974.tb09714.x. [DOI] [PubMed] [Google Scholar]
  54. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., Delon M. R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982 Mar 5;215(4537):1237–1239. doi: 10.1126/science.7058341. [DOI] [PubMed] [Google Scholar]
  55. Wilcock G. K., Esiri M. M., Bowen D. M., Smith C. C. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982 Dec;57(2-3):407–417. doi: 10.1016/0022-510x(82)90045-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES